FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306769422> ?p ?o ?g. }

• W4306769422 endingPage "924" @default.
• W4306769422 startingPage "918" @default.
• W4306769422 abstract "The aim of the study was to evaluate whether a new and successful treatment opportunity can be provided in acute pancreatitis and may prevent symptomatic treatments and show its effect through etiopathogenesis. Therefore, we want to investigate the efficacy of golimumab in an experimental rat model of cerulein-induced acute pancreatitis.A total of 35 rats, including 7 rats in each group, were distributed into 5 groups (sham, acute pancreatitis, placebo, acute pancreatitis+golimumab 5 mg/kg, and acute pancreatitis+golimumab 10 mg/kg). An experimental cerulein-induced acute pancreatitis model was accomplished by intraperitoneal cerulein injections. After sacrification, rat blood samples were collected for amylase, IL-6, and IL-1beta measurements. Histopathological analysis of the pancreas was performed with Tunel and hematoxylin and eosin staining.Amylase, IL-6, and IL-1beta levels were found to be increased in the acute pancreatitis group. IL-1beta, amylase, IL-6 levels, and pancreatic inflammation were all significantly decreased in golimumab groups (P < .01). Moreover, in both golimumab groups, golimumab treatment significantly reduced apoptosis in pancreatic tissues (P < .05). Golimumab treatment was found to significantly reduce edema formation, inflammation, vacuolization, and fat necrosis of pancreatic tissues (P < .05).Firstly in the literature, we investigated the efficacy of golimumab in the experimental acute pancreatitis model. In the light of our findings, it could be suggested that golimumab may be an effective and safe therapeutic option in the treatment of patients with acute pancreatitis." @default.
• W4306769422 created "2022-10-19" @default.
• W4306769422 creator A5008078447 @default.
• W4306769422 creator A5010969016 @default.
• W4306769422 creator A5026869302 @default.
• W4306769422 creator A5034752243 @default.
• W4306769422 creator A5036857475 @default.
• W4306769422 creator A5056428231 @default.
• W4306769422 date "2022-11-21" @default.
• W4306769422 modified "2023-09-27" @default.
• W4306769422 title "Golimumab Ameliorates Pancreatic Inflammatory Response in the Cerulein-Induced Acute Pancreatitis in Rats" @default.
• W4306769422 cites W1967881144 @default.
• W4306769422 cites W1984261925 @default.
• W4306769422 cites W2003030880 @default.
• W4306769422 cites W2067582182 @default.
• W4306769422 cites W2083619053 @default.
• W4306769422 cites W2088054149 @default.
• W4306769422 cites W2108965191 @default.
• W4306769422 cites W2111982579 @default.
• W4306769422 cites W2138589314 @default.
• W4306769422 cites W2157525618 @default.
• W4306769422 cites W2344133937 @default.
• W4306769422 cites W2765351764 @default.
• W4306769422 cites W2944785930 @default.
• W4306769422 cites W2952764100 @default.
• W4306769422 cites W3026836873 @default.
• W4306769422 cites W3087098694 @default.
• W4306769422 cites W3099245374 @default.
• W4306769422 cites W3107485285 @default.
• W4306769422 cites W3113441332 @default.
• W4306769422 cites W3115927424 @default.
• W4306769422 cites W3152764455 @default.
• W4306769422 cites W3156412953 @default.
• W4306769422 doi "https://doi.org/10.5152/tjg.2022.21456" @default.
• W4306769422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36262104" @default.
• W4306769422 hasPublicationYear "2022" @default.
• W4306769422 type Work @default.
• W4306769422 citedByCount "0" @default.
• W4306769422 crossrefType "journal-article" @default.
• W4306769422 hasAuthorship W4306769422A5008078447 @default.
• W4306769422 hasAuthorship W4306769422A5010969016 @default.
• W4306769422 hasAuthorship W4306769422A5026869302 @default.
• W4306769422 hasAuthorship W4306769422A5034752243 @default.
• W4306769422 hasAuthorship W4306769422A5036857475 @default.
• W4306769422 hasAuthorship W4306769422A5056428231 @default.
• W4306769422 hasBestOaLocation W43067694221 @default.
• W4306769422 hasConcept C125473707 @default.
• W4306769422 hasConcept C126322002 @default.
• W4306769422 hasConcept C170493617 @default.
• W4306769422 hasConcept C170835558 @default.
• W4306769422 hasConcept C17991360 @default.
• W4306769422 hasConcept C181199279 @default.
• W4306769422 hasConcept C185592680 @default.
• W4306769422 hasConcept C204232928 @default.
• W4306769422 hasConcept C2775967933 @default.
• W4306769422 hasConcept C2776670229 @default.
• W4306769422 hasConcept C2776731452 @default.
• W4306769422 hasConcept C2777226972 @default.
• W4306769422 hasConcept C2777593968 @default.
• W4306769422 hasConcept C2778764654 @default.
• W4306769422 hasConcept C2780886150 @default.
• W4306769422 hasConcept C2781290027 @default.
• W4306769422 hasConcept C503630168 @default.
• W4306769422 hasConcept C55493867 @default.
• W4306769422 hasConcept C71924100 @default.
• W4306769422 hasConcept C90924648 @default.
• W4306769422 hasConceptScore W4306769422C125473707 @default.
• W4306769422 hasConceptScore W4306769422C126322002 @default.
• W4306769422 hasConceptScore W4306769422C170493617 @default.
• W4306769422 hasConceptScore W4306769422C170835558 @default.
• W4306769422 hasConceptScore W4306769422C17991360 @default.
• W4306769422 hasConceptScore W4306769422C181199279 @default.
• W4306769422 hasConceptScore W4306769422C185592680 @default.
• W4306769422 hasConceptScore W4306769422C204232928 @default.
• W4306769422 hasConceptScore W4306769422C2775967933 @default.
• W4306769422 hasConceptScore W4306769422C2776670229 @default.
• W4306769422 hasConceptScore W4306769422C2776731452 @default.
• W4306769422 hasConceptScore W4306769422C2777226972 @default.
• W4306769422 hasConceptScore W4306769422C2777593968 @default.
• W4306769422 hasConceptScore W4306769422C2778764654 @default.
• W4306769422 hasConceptScore W4306769422C2780886150 @default.
• W4306769422 hasConceptScore W4306769422C2781290027 @default.
• W4306769422 hasConceptScore W4306769422C503630168 @default.
• W4306769422 hasConceptScore W4306769422C55493867 @default.
• W4306769422 hasConceptScore W4306769422C71924100 @default.
• W4306769422 hasConceptScore W4306769422C90924648 @default.
• W4306769422 hasIssue "11" @default.
• W4306769422 hasLocation W43067694221 @default.
• W4306769422 hasLocation W43067694222 @default.
• W4306769422 hasLocation W43067694223 @default.
• W4306769422 hasOpenAccess W4306769422 @default.
• W4306769422 hasPrimaryLocation W43067694221 @default.
• W4306769422 hasRelatedWork W1987542413 @default.
• W4306769422 hasRelatedWork W2010941908 @default.
• W4306769422 hasRelatedWork W2058562050 @default.
• W4306769422 hasRelatedWork W2364027592 @default.
• W4306769422 hasRelatedWork W2411159413 @default.
• W4306769422 hasRelatedWork W2413063882 @default.

• next